深入药物研发的缝隙2025(英)
2025-05管理咨询43免费
报告维度
- 📄 文件全名
- 《深入药物研发的缝隙2025(英)-43页.pdf》
- 🎯 适合读者
- 战略规划行业研究员
- 📊 核心数据
- Total Pipeline Size Has Grown by 4.6%
- ▪ 2024 was up 7.2%
- ▪ 38.8% were anticancers
- ▪ 13.8% neurologicals
- 🏷️ 核心议题
- #管理咨询
Pharma R&D Review 2025 Ian Lloyd, Senior Director, Pharmaprojects Alex Shimmings, Executive Editor, Scrip
Pharma R&D Review 2025 Ian Lloyd, Senior Director, Pharmaprojects Alex Shimmings, Executive Editor, Scrip核心数据:Total Pipeline Size Has Grown by 4.6%;▪ 2024 was up 7.2%;▪ 38.8% were anticancers。
覆盖 2025 年,全文约 43。
本报告免费查阅,登录资料宝后即可在线获取完整内容。
适合战略规划、行业研究员等读者参考。
重点分析了管理咨询等议题。